Code : 17663      Created Date : Wednesday, February 3, 2016   Update Date : Sunday, October 2, 2016    Visit : 2794

James Gustave Kahn

Philip R. Lee Institute for Health Policy Studies

University of California, San Francisco

3333 California Street Suite 265, Box 0936

San Francisco, CA 94118



Professional biography:

Dr. Kahn is a Professor of Health Policy and Epidemiology at the Philip R. Lee Institute for Health Policy Studies, the Department of Epidemiology and Biostatistics, and Global Health Sciences, all at UCSF. Dr. Kahn is an expert in policy modeling in health care, cost-effectiveness analysis, and evidence-based medicine. His work focuses on the use of cost-effectiveness analysis to inform decision-making in public health and medicine.

He is particularly interested in the cost effectiveness of HIV prevention and treatment in resource-constrained global health settings. He has also evaluated interventions for malaria, diarrhea, gestational diabetes, congenital syphilis, pregnancy prevention, and orthopedic devices.

Dr. Kahn has served as consultant to WHO, PEPFAR, IOM and the World Bank on this topic. Dr Kahn’s research has been in Africa (Kenya, Tanzania, Uganda, South Africa), Russia, India and Mexico. Funding for his research projects has been awarded by the CDC, NIH, WHO, the Gates Foundation, the Axios Foundation, Novo Nordisk, and Vestergaard Frandsen.

Dr. Kahn is also interested in U.S. health care financing, in particular the administrative costs of insurance and billing, as well as single payer health care reform. He is the past President of California Physicians for a National Health Program.

Dr. Kahn is the lead instructor in global health economics and cost-effectiveness analysis at UCSF. He has participated in two National Academies of Science / Institute of Medicine studies.

In 2014, Dr. Khan was presented with the TUMS Distinguished Visiting Professor Title for the duration of 2014-2017 by Iranian Netional Center for Addiction Studies.

Research interests:


  • Cost of illness and cost-effectiveness

  • Health care financing

  • Evidence-based medicine

  • International health issues

Most significant publications:


In December 14, 2014, Dr. Khan traveled from University of California San Francisco to Iranian Netional Center for Addiction Studies, Tehran University of Medical Sciences (TUMS) and met with officials of the research center.

During his three day visit, which was on the subject of "Global Health Decisions", the joint implementation of two projects based on the results of the cost effectiveness of HIV and addiction prevention was discussed.

Dr. Khan also had a meeting with Dr. Malekzadeh, deputy for research and Technology, ministry of health and medical education and Dr. Yunesian, Vice Chancellor for Research of TUMS.


Influence beyond the academy (optional)


Inspiring passions and concerns(optional)


Hopes for the Visiting Professor Programme: